MedTrace Logo

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

NCT00002905 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with HIV-related non-Hodgkin's lymphoma that has relapsed or has not responded to chemotherapy.

Conditions

Interventions

DRUG

cyclophosphamide

DRUG

didanosine

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

mitoxantrone hydrochloride

DRUG

prednimustine

DRUG

zidovudine

Sponsors & Collaborators

  • Centro di Riferimento Oncologico - Aviano

    lead OTHER

Principal Investigators

  • Umberto Tirelli, MD · Centro di Riferimento Oncologico - Aviano

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002905 on ClinicalTrials.gov